J. Safra Sarasin Holding 13F: Cuts Xylem (XYL) Stake by $6.3M

J. Safra Sarasin Holding cut its stake in Xylem Inc. (NYSE: XYL) by 56,690 shares, valued at about $6.3 million, in a filing on October 26, 2026. The fund now holds 213,000 shares of Xylem, which represents a 21.0% decrease from its previous position of 269,690 shares.

XYL Xylem Inc.

$108.24 ▼ -20.18% year to date

1M 3M YTD

Daily close · Oct 26, 2026

Where Xylem Fits in J. Safra Sarasin's Portfolio

This position accounts for approximately 0.99% of J. Safra Sarasin's total reported portfolio, ranking 25 out of 800 holdings.

Other Institutional Activity in Xylem

Several other funds have also adjusted their stakes in Xylem. Amundi reduced its holdings by 123,397 shares, leaving it with 5,105,298 shares valued at about $552.6 million. Meanwhile, Bank Of New York Mellon Corporation increased its stake by 3,489,831 shares, totaling 4,672,304 shares worth approximately $505.7 million. Royal Bank of Canada cut its position by 158,142 shares, resulting in 4,605,175 shares valued at about $498.5 million.

Xylem Inc. Stock Down 0.5%

Xylem Inc. shares recently traded around $108.24, which is about equal to its closing price on the filing date. The stock is currently 29.8% below its 52-week high of $154.27 and 9.8% above its 52-week low of $98.58.

Recent Earnings

For the trailing twelve months, Xylem reported revenue of approximately $9.13 billion and earnings per share (EPS) of $4.20. The next earnings report is scheduled for October 27, 2026.

Insider Buying and Selling at Xylem Inc.

In recent insider transactions, Director Victoria D Harker sold 1,700 shares at an average price of $148.14 on November 4, 2025. Meanwhile, Director Jerome A Peribere bought 1,210 shares at $116.61 on May 4, 2026.

Analysts Set New Price Targets

On October 13, 2026, Barclays maintained an Overweight rating on Xylem with a price target of $139.0, while Oppenheimer reiterated an Outperform rating with a target of $150.0 on October 14. RBC Capital also maintained an Outperform rating with a target of $135.0 on the same day.

About Xylem

Xylem Inc. is a company that designs and manufactures products and solutions for water and wastewater applications, serving utility, industrial, and commercial sectors worldwide. This position cut by J. Safra Sarasin reflects ongoing adjustments in their investment strategy.

Bottom Line

Investors should watch for Xylem's upcoming earnings report on October 27, 2026, and keep an eye on further filings from institutional investors regarding their positions. J. Safra Sarasin's recent cut in shares may signal a shift in their outlook on the company.